Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
NAD metabolism and the SLC34 family: evidence for a liver-kidney axis regulating [PMID: 30218374] Laboratory literature summary: NAD metabolism and the SLC34 family: evidence for a liver-kidney axis regulating inorganic phosphate
compounded under Section 503A pharmacy rules Typical research dose / 250-500 mcg subcutaneous injection once daily Lethal dose in humans / none reported in published literature as of May 2026 GH-receptor activation / absent at standard and supra-pharmacologic doses per Heffernan et al
In clinical trial, it produced roughly a 6% reduction in body weight over 68 weeks
The process by which your body turns food into energy is metabolism, and a healthy metabolism helps your body burn calories, even at rest
Growth hormone is released in pulses, with the largest pulse occurring during slow-wave sleep
Refrigerate at 4 C (39 F) immediately upon receipt and during active use
US$ 27.55
US$ 22.89
US$ 25.96
US$ 27.74
US$ 23.25
